Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer

Summary

This trial is going to evaluate tumor control and quality of life in patients with prostate cancer treated with radiotherapy or cryoablation.

Conditions

• Stage III Prostate Cancer

Interventions

PROCEDURE

Cryoablation therapy

Cryoablation therapy

RADIATION

External beam radiation therapy

External beam radiation therapy

DRUG

bicalutamide

bicalutamide

DRUG

luteinizing-hormone releasing-hormone (LHRH) agonist

luteinizing-hormone releasing-hormone (LHRH) agonist

Sponsors & Collaborators

• The Third Xiangya Hospital of Central South University

  collaborator OTHER

• The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  collaborator OTHER

• Peking University First Hospital

  collaborator OTHER

• Shanghai Jiao Tong University School of Medicine

  collaborator OTHER

• Shandong Cancer Hospital and Institute

  collaborator OTHER

• Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

  collaborator OTHER

• Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  collaborator OTHER

• Tianjin First Central Hospital

  collaborator OTHER

• Tianjin Medical University Cancer Institute and Hospital

  lead OTHER

Principal Investigators

• Zhi Guo, PhD · Tianjin Medical University Cancer Institue and Hospital

Study Design

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

MALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-11-30

Primary Completion

2017-12-31

Completion

2018-12-31

Countries

• China

Study Locations